Massmutual Trust CO Fsb Sarepta Therapeutics, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.28 Billion
- Q2 2024
A detailed history of Massmutual Trust CO Fsb transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 113 shares of SRPT stock, worth $16,453. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113
Previous 47
140.43%
Holding current value
$16,453
Previous $6,000
183.33%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SRPT
# of Institutions
479Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA8.8MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$868 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.89MShares$712 Million0.36% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$701 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$633 Million6.78% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $12.8B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...